- Home
- BCTX vs MDRR Comparison
BCTX vs MDRR Comparison
Compare BCTX & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCTX | MDRR |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 18.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BCTX | MDRR |
|---|---|---|
| Price | $9.90 | $13.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 57.6K | 3.9K |
| Earning Date | 12-11-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,098,461.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $380.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.83 |
| 52 Week Low | $6.00 | $9.55 |
| 52 Week High | $106.50 | $15.00 |
Technical Indicators
Market Signals| Indicator | BCTX | MDRR |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 52.07 |
| Support Level | $11.38 | $12.66 |
| Resistance Level | $13.09 | $13.62 |
| Average True Range (ATR) | 1.14 | 0.37 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 30.12 | 45.28 |
Price Performance
Historical ComparisonAbout BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.